Aubel O - Search Results

1

The team effect on doping in professional male road cycling (2005-2016).

Aubel O, Lefèvre B, Le Goff JM, Taverna N. Aubel O, et al. Scand J Med Sci Sports. 2019 Apr;29(4):615-622. doi: 10.1111/sms.13384. Epub 2019 Feb 3. Scand J Med Sci Sports. 2019. PMID: 30636331

2

Doping risk and career turning points in male elite road cycling (2005-2016).

Aubel O, Lefèvre B, Le Goff JM, Taverna N. Aubel O, et al. J Sci Med Sport. 2018 Oct;21(10):994-998. doi: 10.1016/j.jsams.2018.03.003. Epub 2018 Mar 14. J Sci Med Sport. 2018. PMID: 29580881

3

In Situ Time-dependent Dielectric Breakdown in the Transmission Electron Microscope: A Possibility to Understand the Failure Mechanism in Microelectronic Devices.

Liao Z, Gall M, Yeap KB, Sander C, Clausner A, Mühle U, Gluch J, Standke Y, Aubel O, Beyer A, Hauschildt M, Zschech E. Liao Z, et al. Among authors: aubel o. J Vis Exp. 2015 Jun 26;(100):e52447. doi: 10.3791/52447. J Vis Exp. 2015. PMID: 26167933 Free PMC article.

4

An alternative approach to the prevention of doping in cycling.

Aubel O, Ohl F. Aubel O, et al. Int J Drug Policy. 2014 Nov;25(6):1094-102. doi: 10.1016/j.drugpo.2014.08.010. Epub 2014 Sep 6. Int J Drug Policy. 2014. PMID: 25440912

5

Effect of dutasteride on the risk of prostate cancer.

Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group. Andriole GL, et al. N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127. N Engl J Med. 2010. PMID: 20357281 Free article. Clinical Trial.

6

[Inventory and follow-up of patients with surgery for (uterine) vaginal prolapse, combined with or without, (masked) stress incontinence].

Feijen HL, Hutten JW, Noordam MJ, Ramondt J, van Aubel O. Feijen HL, et al. Among authors: van aubel o. Ned Tijdschr Geneeskd. 1998 Apr 4;142(14):811-2. Ned Tijdschr Geneeskd. 1998. PMID: 9646617 Dutch. No abstract available.

7

Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group.

Radlmaier A, Eickenberg HU, Fletcher MS, Fourcade RO, Reis Santos JM, van Aubel OG, Bono AV. Radlmaier A, et al. Among authors: van aubel og. Prostate. 1996 Oct;29(4):199-208. doi: 10.1002/(SICI)1097-0045(199610)29:4<199::AID-PROS1>3.0.CO;2-7. Prostate. 1996. PMID: 8876703 Clinical Trial.

8

Phase I/II study of intravesical epirubicin in patients with carcinoma in situ of the bladder.

Kurth KH, Mross K, ten Kate F, Weissglas G, Carpentier PJ, Krueger CG, Blom J, Groen JM, van Caubergh RD, van Aubel O, et al. Kurth KH, et al. Among authors: van aubel o. Prog Clin Biol Res. 1990;350:41-59. Prog Clin Biol Res. 1990. PMID: 2385609 No abstract available.

9

Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy.

van Aubel OG, Bolt-de Vries J, Blankenstein MA, de Jong FH, Schröder FH. van Aubel OG, et al. Urol Res. 1989;17(2):99-102. doi: 10.1007/BF00262028. Urol Res. 1989. PMID: 2734984

10

Prediction of time to progression after orchiectomy by the nuclear androgen receptor content from multiple biopsy specimens in patients with advanced prostate cancer.

van Aubel O, Bolt-de Vries J, Blankenstein MA, Schröder FH. van Aubel O, et al. Prostate. 1988;12(3):191-8. doi: 10.1002/pros.2990120302. Prostate. 1988. PMID: 3375141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page